<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000612.v1.p1" parentStudy="phs000612.v1.p1" createDate="2013-04-17" modDate="2014-05-23">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Timothy A. Chan, MD, PhD</td><td>Memorial Sloan-Kettering Cancer Center, New York, NY</td></tr>
		<tr><td>Funding Source</td><td>R21DE023229</td><td>National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Funding Source</td><td>RO1CA154767</td><td>National Institutes of Health, Bethesda, MD, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>The mutational characterization of adenoid cystic carcinoma</StudyNameEntrez>
	<StudyNameReportPage>The mutational characterization of adenoid cystic carcinoma</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Case-Control</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>Adenoid cystic carcinoma (ACC) typically emanate from the major and minor salivary glands of the head and neck. ACCs have high rates of perineural invasion, locoregional recurrence, and distant metastasis. Here we report sequencing of 60 tumor/normal pairs and find substantial mutational diversity. On pathway analysis, a significant percentage of mutations involved chromatin remodeling, DNA damage, protein kinase A signaling, and FGF/IGF/PI3K signaling. Whole genome sequencing and FISH confirmed the MYB-NFIB translocation as the main structural variant in ACC. Evaluation of potential driver mutations KDM6A and PIK3CA reveal that specific, observed alterations impart functional consequences. Collectively, our data delineate the ACC mutational landscape and establish a molecular foundation for investigating new therapies for this disease.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p>Inclusion criteria: Histologically confirmed adenoid cystic carcinoma of the head and neck.</p> <p>Exclusion criteria: Adenoid cystic carcinomas of other sites, including breast; distantly metastatic adenoid cystic carcinoma; other salivary malignancies. </p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="23685749"/>
		</Publication>
		<Publication>
			<Pubmed pmid="21147032"/>
		</Publication>
		<Publication>
			<Pubmed pmid="22505352"/>
		</Publication>
		<Publication>
			<Pubmed pmid="21798897"/>
		</Publication>
		<Publication>
			<Pubmed pmid="21798893"/>
		</Publication>
		<Publication>
			<Pubmed pmid="17761983"/>
		</Publication>
		<Publication>
			<Pubmed pmid="22687949"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Cancer"/>
		<Disease vocab_source="MESH" vocab_term="Carcinoma, Adenoid Cystic"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Timothy A. Chan, MD, PhD</AttName>
			<Institution>Memorial Sloan-Kettering Cancer Center, New York, NY</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>R21DE023229</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>RO1CA154767</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="DS-CA" longName="Disease-Specific (Cancer)"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NIDCR</DacName>
      <DacFullName>NIDCR</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000612.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000612.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000612.v1.p1" FileName="suid9349.draft_duc.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>Disease-Specific (Cancer)</ConsentName>
        <ConsentAbbrev>DS-CA</ConsentAbbrev>
        <UseLimitation>Use of the data must be related to Cancer.
May be used for research to learn about, prevent, or treat cancer. May not be used to study inherited genetic factors that cause cancer.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
